Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual reality headsets could replace sedatives for C-Section anxiety

NCT ID NCT07343843

First seen Jan 20, 2026 · Last updated Jun 22, 2026 · Updated 20 times

Summary

This study tests whether wearing a virtual reality headset with calming scenes can reduce anxiety and stress during a cesarean section as well as a sedative drug called dexmedetomidine. Fifty-two women having planned C-sections will be randomly assigned to receive either the VR headset or the drug through an IV. Researchers will measure anxiety levels, heart rate, blood pressure, and how the baby is doing after birth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Benha University

    RECRUITING

    Banhā, Benha, 13518, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Dexmedetomidine (sedative drug) and virtual reality (immersive audiovisual content)

What this could lead to

If successful, this could offer a non-drug option (VR) to reduce anxiety during C-sections, avoiding potential side effects of sedatives.

What could go wrong

This is a small, early-stage study (52 participants) comparing two interventions, so results may not apply broadly. The VR approach may not work for everyone, and the drug has known risks like low blood pressure.

Conditions

The condition(s) this trial relates to.

anxiety

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.